Efficacy and prediction analysis of pegylated interferon alpha-2b in treatment-naive HBeAg negative chronic hepatitis B patients with normal ALT: a multicenter real-world study (Ice-breakting Project in China)-Interim analysis

被引：0

作者：

Zhang, Chong ^{[1
]}

Zeng, Da-Wu ^{[2
]}

Cai, Da-Chuan ^{[3
]}

Xue, Xiu-Lan ^{[4
]}

Zhang, Ling-Yi ^{[5
]}

Song, Bao-Jun ^{[6
]}

Gao, Yu-Feng ^{[7
]}

Huang, Yan ^{[8
]}

Shang, Jia ^{[9
]}

Wu, Xiao-Feng ^{[10
]}

Zhang, Ying ^{[11
]}

Jin, Hua ^{[12
]}

Chen, Hui ^{[13
]}

Tang, Hong ^{[14
]}

Lu, Xiaobo ^{[15
]}

Guan, Yujuan ^{[16
]}

Min, Feng ^{[17
]}

Xu, Liang ^{[18
]}

Li, Gang ^{[19
]}

Wang, Zhen-Guang ^{[20
]}

Dou, Xiaoguang ^{[1
]}

机构：

[1] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China

[2] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China

[3] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China

[4] Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China

[5] Lanzhou Univ, Hosp 2, Lanzhou, Peoples R China

[6] Sixth Peoples Hosp Fushun, Fushun, Peoples R China

[7] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China

[8] Cent South Univ, Xiangya Hosp, Changsha, Peoples R China

[9] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China

[10] Sixth Peoples Hosp Shenyang, Shenyang, Peoples R China

[11] Dalian Publ Hlth Med Ctr, Dalian, Peoples R China

[12] Sixth Peoples Hosp Benxi, Benxi, Peoples R China

[13] Hepatobiliary Hosp Jilin, Changchun, Jilin, Peoples R China

[14] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China

[15] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China

[16] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Peoples R China

[17] Army Seventy Three Army Hosp, Beijing, Peoples R China

[18] Tianjin Second Peoples Hosp, Tianjin, Peoples R China

[19] Liaohe Oilfield Gen Hosp, Panjin, Peoples R China

[20] Anshan City Hosp Infect Dis, Anshan, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-193

引用

页码：S1165 / S1166

页数：2

共 50 条

[21] Safety and efficacy of an escalating dose regimen of pegylated interferon alpha-2b in the treatment of haemodialysis patients with chronic hepatitis C
Tan, S. S.
Abu Hassan, M. R.
Abdullah, A.
Ooi, B. P.
Korompis, T.
Merican, M. I.
JOURNAL OF VIRAL HEPATITIS, 2010, 17 (06) : 410 - 418
[22] HBV viral dynamics during treatment of naive patients with HBeAg(-) chronic hepatitis B with pegylated interferon alpha 2b alone or in combination with lamivudine
Sypsa, V
Mimidis, K
Tassopoulos, NC
Chrysagis, D
Vassiliadis, T
Moulakakis, A
Raptopoulou, M
Haida, C
Hatzakis, A
HEPATOLOGY, 2004, 40 (04) : 668A - 669A
[23] Pegylated interferon-alfa 2b (PEG IFN-α2b) monotherapy among treatment-naive hepatitis B e antigen (HBeAg)-positive, HBeAg-negative, and Lamivudine-resistant chronic hepatitis B patients
Sollano, J. D.
Co, J. T.
Nilo, G. S.
Lim, E. L.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A470 - A470
[24] SEQUENTIAL THERAPY WITH TENOFOVIR AND PEGYLATED INTERFERON-ALPHA2b VERSUS TENOFOVIR MONOTHERAPY IN HBeAg POSITIVE CHRONIC HEPATITIS B (CHB): AN INTERIM ANALYSIS
Jindal, A.
Kumar, M.
Sarin, S. K.
JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S441 - S442
[25] Real-world treatment patterns and clinical outcomes of HCV treatment-naive patients in China: an interim analysis from the CCgenos study
Rao, Hui-ying
Li, Hong
Chen, Hong
Shang, Jia
Xie, Qing
Gao, Zhi-Liang
Li, Jun
Sun, Yongtao
Jiang, Jianning
Wang, Lei
Zhao, Longfeng
Zhang, Lunli
Yang, Weibo
Niu, Junqi
Gong, Zuojiong
Gong, Guozhong
Yang, Ruifeng
Lee, Mei-Hsuan
Wei, Lai
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (01) : 244 - 252
[26] Entecavair versus tenofovir in treatment-naive chronic Hepatitis B patients: Real-world data from the realist* study
Mete, Bilgul
Ceylan, Bahadir
Ozgunes, Nail
Gunduz, Alper
Karaosmanoglu, Hayat Kumbasar
Cagatay, Atahan
Gokturk, Kadir
Erdem, Levent
Kocak, Funda
Gorenek, Levent
Aslan, Turan
Senates, Ebubekir
Ozaras, Resat
Colak, Onur
Tabak, Fehmi
HEPATOLOGY, 2012, 56 : 356A - 356A
[27] Efficacy of pegylated interferon alpha-2b in combination with ribavirin in patients with chronic hepatitis C non-responders to a previous treatment
Chousterman, M
Auray-Cartier, V
Hagege, H
Arpurt, JP
Cassan, P
Denis, J
Gargot, D
Nalet, B
Nouel, O
Pariente, A
Wartelle-Bladou, C
JOURNAL OF HEPATOLOGY, 2003, 38 : 133 - 134
[28] Long-Term Real-World Outcomes of Tenofovir Alafenamide in Chronic Hepatitis B: Detailed Analysis of Treatment-Naive and Experienced Patients
Song, Yu-Xuan
Song, Guang-Jun
Ma, Hui
Feng, Bo
Xie, Yan-Di
KOREAN JOURNAL OF GASTROENTEROLOGY, 2025, 85 (01): : 64 - 72
[29] FUNCTIONAL CURE BASED ON PEGYLATED INTERFERON α IN LONG-TERM NUCLEOSIDE ANALOG SUPPRESSED HBEAG NEGATIVE CHRONIC HEPATITIS B: A MULTICENTER REAL-WORLD STUDY (EVEREST PROJECT IN CHINA), A SEQUENTIAL REPORT - THE PREDICTORS FOR HBsAg LOSS
Wu, Zeqian
Xie, Dongying
Fu, Lei
Zhang, Wenhua
Wei, Jia
Shang, Jia
Li, Guojun
Guo, Ying
Yang, Jiahong
Guan, Yujuan
Li, Jiabin
Chang, Jiabao
Huang, Guangyu
Peng, Yanzhong
Lin, Minghua
Zeng, Yilan
Li, Jia
Jiang, Jiaji
Jiang, Yongfang
Gu, Ye
Geng, Jiawei
Gao, Zhiliang
HEPATOLOGY, 2021, 74 : 483A - 483A
[30] Functional cure based on pegylated interferon α in long-term nucleoside analog suppressed HBeAg negative chronic hepatitis B: A multicenter real-world study (everest project in china), a sequential report the predictors for HBsAg loss
Wu, Ze-Qian
Xie, Dong-Ying
Fu, Lei
Zhang, Wenhua
Wei, Jia
Shang, Jia
Li, Guojun
Guo, Ying
Yang, Jiahong
Guan, Yujuan
Li, Jiabin
Chang, Jiabao
Huang, Guangyu
Peng, Yanzhong
Lin, MInghua
Zeng Yilan
Li, Jia
Jiang, Jiaji
Jiang, Yongfang
Gu, Ye
Geng, Jiawei
Gao, Zhi-liang
JOURNAL OF HEPATOLOGY, 2021, 75 : S759 - S759

← 1 2 3 4 5 →